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ABSTRACT 
 
Detection of Atherosclerotic Coronary Plaques by  
 Fluorescence Lifetime Imaging Angioscopy.  
(August 2010) 
Patrick Allen Thomas, B.S., Louisiana Tech University 
Chair of Advisory Committee: Dr. Javier Jo 
  
 
 
Vulnerable plaque is a clinically silent condition of atherosclerotic plaque that 
leaves a large number of patients at risk of a coronary event. A method to detect 
vulnerable atherosclerotic plaque would greatly enhance the ability of clinicians to 
diagnose and treat patients at risk. Fluorescence lifetime imaging microscopy (FLIM) 
offers a way to extract both spatial and biochemical information from plaque by taking 
several wide-field images over time. The goal of this study was to determine the 
potential of a FLIM angioscopy system to detect and differentiate coronary 
atherosclerotic plaques ex-vivo into several groups including thin, fibrotic, lipid-laden, 
thick-cap fibroatheroma (FA), and fibrocalcified. 
Samples were extracted post-mortem weekly and sliced open to have their 
lumens imaged. For each sample, 51 time resolved wide-field images were taken over 10 
nanoseconds at 390 (±40) nm, 450 (±40) nm, and 550 (±88) nm wavelengths. To analyze 
the samples, the intensity map and lifetime map were created at each wavelength. The 
intensity map was simply the wide-field images summed in time and normalized. In 
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order to calculate lifetime at each point, a fast, model-free Laguerre deconvolution 
algorithm was recently developed for FLIM data analysis and was used. This allowed for 
fast, efficient estimations of the fluorescence decay curves at each pixel of the FLIM 
images and facilitated the computation of quantitative parameters describing the 
fluorescence emission of the tissue, specifically, the relative fluorescence intensity and 
lifetime at defined emission bands.  
Statistical analysis on these FLIM derived parameters indicated that the 
autofluorescence emission of the plaques allows for distinguishing relative plaque 
thickness: thin plaque, whose signal is dominated by elastin fluorophores, shows a 
marked difference between thicker plaques, such as fibrotic, fibrocalcified and thick-cap 
FA (who are dominated primarily by collagen). However, the ability of the current FLIM 
system to differentiate vulnerable plaque remains in question due to the absence of thin-
cap FA samples. Further work has also been proposed; of primary concern is gathering 
thin-cap FA plaque samples needed to validate the system’s ability to differentiate 
vulnerable plaques from other common groupings. 
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1. INTRODUCTION 
 
 Fluorescence imaging has the potential to extract biochemical information from 
tissue (1-3). In some cases, utilizing the autofluorescent signal produced by biological 
fluorophores in the tissue of interest leads to distinguishing normal conditions from 
pathologically effected tissue (4-5). This is possible because every known fluorophore 
possesses unique excitation and emission spectra, allowing biochemical information to 
be determined. Sometimes, however, these spectra overlap significantly, posing a 
problem in discerning fluorophores, especially when two or more are present in the 
region of interest. Fortunately, a second parameter known as the fluorescence lifetime, 
which describes the time it takes for an emission to decay in intensity after stimulation, 
may be used as a way to identify fluorophores. Fluorescence lifetime imaging 
microscopy (FLIM) utilizes both spatially and temporally resolved information to 
distinguish fluorophores in space for size measurements as well as chemical 
identification.  
 
 
 
 
 
 
 
 
 
____________ 
This thesis follows the style of Journal of Photochemistry and Photobiology. 
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 The purpose of this research was to examine the potential of FLIM to 
characterize biochemical composition of atherosclerotic coronary plaques. To fulfill this 
objective, the two specific aims of this work were: 
 Aim 1: Collect a database of FLIM data images from post-mortem human 
coronary plaques and their underlying histopathology. A FLIM angioscope was 
used to image the lumen of coronary plaques. The imaged plaque tissue sections 
were sent for histopathology analysis. Plaques were procured and imaged from 
15 subjects. 
 Aim 2: Determine a set of FLIM features that could allow the quantification 
of plaque composition. The FLIM images were processed to derive a set of 
parameters quantifying the plaque autofluorescence (such as relative intensity 
and lifetime values at different emission bands). The resulting parameters were 
statistically correlated to the plaque histopathology. 
In the following work, the FLIM system’s ability to differentiate ex vivo 
coronary plaque types is investigated. It was found that intensity, lifetime, and laguerre 
expansion coefficients were good identifiers of certain plaque types, primarily based on 
plaque thickness due to shifts in dominant fluorophores. Elastin gives a strong 
fluorescent signal with thin plaques, while collagen dominates the fluorescent signal in 
thick plaques and calcified plaques. Unfortunately, very little plaques with thin cap 
fibibroatheromas were available, making it impossible to perform statistical analysis on 
vulnerable plaques. 
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2. BACKGROUND 
 
2.1 Atherosclerosis 
Atherosclerosis is an intravascular disease in which lipids build up in the lumen 
of a blood vessel over time. This condition can lead to several life-threatening 
complications. In 2008, 1.49 million Americans suffered from a myocardial infarction, 
in which 560,000 did not survive (6). About 70% of all coronary events are related to the 
rupture of atherosclerotic plaque buildup, primarily due to thrombosis at the plaque 
rupture site (7). Plaque buildup begins early in life as a simple aggregate of lipid cells 
entrenched in a collagen matrix on the surface of the lumen. As the plaque becomes 
larger, inflammatory cells migrate into the site and begin to metabolize the lipid cells, 
forming foam cells. As time goes on, a collagen matrix begins to wall off the lipid core.  
The cap, or the collagen-lipid matrix between the lumen and the core, may be thick 
enough to withstand shear forces from the blood flow, leading to a stable plaque. On the 
other hand, thin cap plaques (usually having < 65µm cap thicknesses) are prone to 
rupture and referred to as thin-cap fibroatheromas (TCFA) (8). Vulnerable plaque is 
specifically defined as mildly to moderately stenotic plaque that are precursors to 
coronary thrombosis and myocardial ischemia (9). TCFA is one of the major types of 
vulnerable plaque, causing a thrombolytic response at the rupture site, subsequently 
leading to partial or complete occlusion of the vessel. This study focused primarily on 
differentiating TCFA and the lipid core below it to analyze vessel plaques.  
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Patients prone to atherosclerotic buildup include age, lipid-rich diet, and genetics. 
Lipids buildup often goes unnoticed until a coronary event occurs, thus making 
atherosclerosis clinically silent. Without a simple, definitive method to determine plaque 
vulnerability, atherosclerosis will continue to be a prevalent cause of coronary events, 
and therefore fatal incidents, around the world. 
 
2.2 Current Intravascular Imaging Methods of Atherosclerosis 
 The first and most established technique for intravascular detection of 
atherosclerotic plaque is Intravascular Ultrasound, or IVUS. IVUS is the adaption of 
ultrasonography to intravascular applications and returns A-line scans (A-line scans are 
lines of spatially resolved information which radiates from the detector at some certain 
angle). These A-line scans are taken as the IVUS catheter rotates, producing cross 
sectional images called B-scans. However, this technique suffers from poor spatial 
resolution and the inability to differentiate soft tissue components (10). Furthermore, 
calcium deposits, which are common sites of late-stage atherosclerotic plaque, are easily 
identifiable due to the radial “shadows” they leave behind them due to their ability to 
largely absorb acoustic waves. This presents a problem by masking any features behind 
the calcium deposit (11).  
 Optical Coherence Tomography (OCT) presents another way to scan the physical 
tomography of a surface, giving similar information as IVUS. OCT has received a 
decent amount of attention in recent years for its high spatial resolution. Some groups 
have found that it can detect macrophages, a sign of plaque vulnerability (12-13). OCT 
5 
 
 
5
 
has not yet become a mainstream technique for intravascular plaque detection, however. 
OCT utilizes optical interferometry to reconstruct spatial images of the vessel wall by 
comparing the phase and intensity differences between the reference optical path and the 
optical path that interacts with the vessel (10). This method scans the surface to construct 
diagnostically relevant images, eventually producing cross sectional images of the blood 
vessel of interest through A-line scanning. The axial resolutions of current OCT systems 
are between 10 and 20µm, although highly scattering mediums such as hemoglobin may 
increase these numbers (10, 14-15). OCT is advantageous for detecting TCFA’s because 
of its ability to gather microscopic information from the surface of plaques (9) and its 
high resolution. However, 3D scanning requires saline flushing of the vessel to offset the 
effect of hemoglobin and water absorption and reduce noise. Finally, OCT generates 
purely structural and morphological information, with little to no biochemical 
information accessible. Thus, it would be advantageous if OCT were coupled with other 
optical methods to gain a full view of the nature of the plaque. 
 Optical Spectroscopy techniques, including Fluorescence, Raman and NIR 
Spectroscopies, have also been explored as methods to detect plaques. Fluorescence is a 
specific response to photon excitation that results in the unique emission of photons at 
wavelengths longer that the excitation wavelength. The unique emission of various 
fluorophores allows for chemical composition detection of the illuminated area. It is 
possible to recover spatially resolved images with fluorescence, depending on collection 
mechanism. The excitation wavelength tends to be either in the UV range or visible 
range to maximize excitation of the fluorophores intrinsic in the tissue (16-18). 
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Fluorescence spectroscopy receives its contrast by varying degrees of fluorescent 
intensity response as a function of emission wavelength. Fluorescence spectroscopy 
alone, without being temporally resolved, usually involves ratiometric measurement of a 
single point at different wavelengths, and has detected plaque ex vivo (18). A major 
advantage of this method is that it is a proficient detector of atherosclerotic plaque, and 
the ease of recording a sample’s entire spectral response to excitation. However, it lacks 
sufficient spatial information to gauge intravascular plaque sizes. Temporally resolved 
measurements, as seen in Fluorescence Lifetime Imaging Micrcosopy systems, are more 
robust due to relative intensity measurement required for fluorescence lifetime 
calculation, as well as an added lifetime parameter to characterize plaques.  
Raman spectroscopy is a non-destructive optical technique that acquires 
biochemical information of the tissue and can specifically target calcium-laden and 
cholesterol-laden plaques (19). Raman spectroscopy excites in the NIR and IR 
wavelength range to observe changes in excitation of vibrational energy states, rather 
than the larger electronic states of atoms and molecules. Raman has been combined with 
other modalities, such as Diffuse Reflectance Spectroscopy (DRS) or Fluorescence 
Spectroscopy (20). A major advantage to this technique is that these vibrational energy 
peaks are very specific to bonding types and atoms in a molecule, thus making it easier 
to identify bulk biological compounds. The disadvantages of this technique are 
threefold: first, the low signal level resulting in a long signal integration time (the 
amount of time the recording element collects a signal in a given recording period) 
required. Some report collection times of up to 100 seconds (21), which becomes a 
7 
 
 
7
 
problem when taking measurements in a clinical setting: longer recording times increase 
the probability of artifacts and risk to the patient. Second, fluorescence emission usually 
is present when recording Raman signals, and must somehow be separated from the 
intended Raman signal.  Third, this technique cannot extract a significant amount of 
depth information past a few hundred micrometers (19). Although Raman spectroscopy 
affords a great deal of biochemical information, the ability to spatially resolve the region 
of interest would be invaluable in evaluating the size and thickness of necrotic cores and 
other signs of vulnerable plaque. 
Intravascular NIR Spectroscopy is advantageous because blood absorption does 
not occur as prominently at these wavelengths. NIR Spectroscopy measures both 
absorption and scattering spectra to characterize cholesterol and collagen content in 
plaques (22). NIR and Mid-IR detection systems also penetrate deeper into tissue, a 
definite advantage when differentiating vulnerable and stable plaques (23). However, 
NIR spectroscopy alone has difficulty correlating plaque thickness and lipid core depth, 
an important parameter of vulnerable plaque detection (24).  
In summary, these techniques (OCT, IVUS, and Optical Spectroscopy 
techniques) have strengths and weaknesses, and none have yet been determined to be the 
definitive intravascular diagnostic tool for intravascular atherosclerotic plaque detection. 
Therefore, there is still room for investigating other techniques in atherosclerotic plaque 
differentiation. 
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2.3 Fluorescence Lifetime Imaging Microscopy (FLIM) 
2.3.1 Fluorescence 
When molecules and atoms absorb light, their electrons can transition from a 
ground state to an excited state. To return to ground state, the molecules may give off the 
absorbed energy as either radiative decay or non-radiative decay. If the electrons are in 
the more common singlet state, the electrons will emit energy quickly (within a few 
nanoseconds) as the electrons return to ground state (25). The energy released radiates at 
certain wavelength spectra, which equates to specific energy emission bands 
characteristic of the materials under illumination. The phenomenon of singlet-state 
energy radiative decay is known as fluorescence. Fluorophores, or materials that 
efficiently release energy in this manner (radiative decay), have been used for a variety 
of purposes, ranging from flow velocimetry to embryological development tracking (26-
27). These uses are made possible due to several hundred different fluorophores having 
unique absorption and emission spectra, as well as unique lifetime. The absorption 
spectrum represents the efficiency of photon absorption across varying wavelengths. 
Similarly, the emission spectrum describes the efficiency of the excited fluorophore to 
emit photons at varying wavelengths. The lifetime describes a fluorophore’s tendency to 
emit photons as a function of time. 
These two spectra differ due to a phenomenon known as the Stoke’s Shift, which 
is a result of photons emitted having less energy than the photons used to excite the 
fluorophore. Specifically, the wavelength of an incoming photon to be absorbed by the 
fluorophore can be represented by some amount of energy through Planck’s Law: 
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 (1) 
E is the energy of a single photon, h is Planck’s constant, v is the velocity of the 
photon (a function of the medium it is traveling through), and λ represents the 
wavelength, usually in nanometers. All materials have quantifiable energy levels that 
determine the energy required to excite an electron from its ground state to an excited 
state, making fluorescence possible.  
 
 
Figure 1. Jablonski Diagram (28). 
 
The Stoke’s Shift will be explained with the help the Jablonski Diagram (Figure 
1). As energy in the form of photons enter the system, electrons leave their resting 
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electronic state (S0) to occupy a higher electronic state, denoted by S1 and S2. An 
electron may occupy any vibrational energy state upon excitation, shown in Figure 1 as 
the lines within each electronic state with small increments between each other. Excited 
molecules lose some energy in the process known as internal conversion prior to 
returning to ground state, as illustrated. After internal conversion, the electrons of a 
fluorophore will then release the rest of its absorbed energy by emittiong a photon, 
forming the fluorophore’s emission discussed earlier. Not all electrons will emit a 
photon to return to ground state: the quantum yield is a measure of the amount of 
photons emitted vs. the number of photons absorbed. The intensity spectrum absorbed is 
primarily a function of the quantum yield, excitation wavelength, and molar extinction 
coefficient (the absorbing power) of the fluorophore of interest (25). 
With a sample of a single fluorophore type, the fluorescence intensity will 
generally follow a single exponential decay as more and more individual fluorophores 
emit photons, returning to ground state. Fluorescence lifetime follows first order kinetics 
and can be calculated using the following equation: 
          
      
           (2) 
The lifetime τn is related to the decay rate of the excited species, and is given by 
equation 3: 
          
   (3) 
 Lifetime changes across the emission spectrum in complex fluorescence systems 
such as tissue, making it a powerful parameter to further identify fluorophores that may 
have similar or overlapping emission spectra. In the case of such systems, multiple 
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fluorophores usually are present and can be represented by a multiexponential 
summation of n fluorophores. In this research, three fluorophores intrinsic to blood 
vessels and plaque are stimulated: collagen, elastin, and lipids. These three fluorophores 
allow for marker-less fluorescence measurements and the possibility of plaque detection 
via fluorescence and lifetime measurements.  
 The issue of penetration depth should be discussed in brief. There is a limit to 
how deep a fluorophore may be imaged due to adsorption and scattering in the sample 
medium as well as the limitations of optical setup. In the case of vulnerable 
atherosclerotic plaque detection, a penetration depth of 65µm (the thickness of a thin cap 
FA) or higher is required to differentiate thin cap FA’s. Higher penetration depths are 
desired, however, in order to extract more information about the biochemistry of the 
underlying core. With an UV excitation (~337 nm) into vessel tissue, the penetration 
depth is expected to be roughly 200 µm, which should adequately extract fluorescent 
signals from lipid cores with thin caps (1). 
 
2.3.2 Fluorescence Lifetime Imaging Microscopy 
 Fluorescence Lifetime Imaging Microscopy (FLIM) is an imaging modality that 
spatially resolves fluorescence lifetime information from a sample, which in turn 
provides biochemical information in the field of view. Wide-field time-gated imaging, 
the specific FLIM modality utilized in this study, gathers a series of temporally wide 
field images to build intensity and lifetime profiles in the field of view. There are several 
potential advantages of using FLIM for VP detection. First, FLIM spatially resolves 
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fluorophores over the field of interest, making it possible to identify the size of plaque 
features. Secondly, by using relative intensity measurements, lifetime parameters can be 
extracted even at low signal strength: light absorbers and the optical path of the system 
will not alter lifetime measurements. This also allows the intensity measurements 
between samples to be different while still allowing meaningful comparison of lifetimes 
between samples. Finally, the extra parameter of lifetime gives additional ways to 
analyze fluorescence data for biochemical, and thus histopathological, characterization. 
These equate to a robust measurement modality that may have potential for 
atherosclerotic plaque detection. 
Provided that the field of view is large enough, FLIM can potentially determine 
plaque features like collagen-rich plaques and necrotic cores, due to changes in 
fluorescence intensity and lifetime throughout the sample. When coupled with other 
modalities, FLIM can reinforce the findings of other imaging modalities looking at 
morphological structure (29). In the mentioned paper, OCT and FLIM are utilized in 
tandem to extract both morphological and biochemical information of the region of 
interest. The fluorophores of interest lend themselves to fluorescence lifetime techniques 
due to their overlapping intensity emission spectra. Collagen has a higher intensity 
measurements than elastin at 390 nm, and elastin peaks at roughly 450 nm; however, a 
large amount of overlap remains. Lifetime measurements show very distinct lifetimes at 
lower wavelengths (elastin: ~2 ns, collagen: 1-1.5 ns), making FLIM an ideal choice for 
spatially mapping collagen, and therefore plaque, in coronary vessels (30-31). The added 
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lifetime parameter therefore places diagnostically relevant features into more 
differentiable categories by increasing the amount of fluorescence information available. 
Finally, Fluorescence Lifetime Imaging Microscopy offers a relatively high 
signal-to-noise ratio. This avoids overly-high integration time, as seen frequently in 
Raman Spectroscopy, making signal collection faster and more reliable in a 
heterogeneous environment. FLIM therefore deserves to be explored as a detection 
modality for vulnerable atherosclerotic plaques.   
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3. METHODS 
 
3.1 FLIM System and Sample Recording 
 The FLIM setup is a wide-field time-gated system with a field of view of 3mm 
(diameter). The FLIM angioscope is bifurcated, consisting of a common distal end 
containing 10,000 bundled, coherent collection fibers (350/450 μm inner/outer diameter, 
Fujikura, Japan) surrounded by 200 illumination fibers (50/66 μm inner/outer diameter, 
0.22 NA, High OH silica/silica for UV transmission). The distal end of the imaging 
probe was cemented to a gradient index objective lens (350 μm diameter, 0.5 NA, 4 mm 
working distance, GRINTECH GmbH, Germany). The distal end splits into two 
proximal ends: the proximal illumination fiber and the proximal collection fiber. The 
proximal illumination fiber terminates with a SMA-905 connector, and the proximal 
collection bundle was flat polished. The entire fiber bundle is ~2m long and has an outer 
diameter of 2mm at the distal (thicker) end.  
 A digital signal delay generator synchronizes the ICCD camera gating with the 
pulsed laser illumination. The pulsed nitrogen laser (Center wavelength~337nm, 700 ps 
pulse width, MNL 205, LTB Lasertechnik, Germany) sends a pulse at 50 Hz, entering 
the proximal illumination fiber bundle, and reaches the XYZ sample stage containing the 
artery sample. The sample generates a fluorescent signal, illuminates the collection 
bundle, coherently travels through the collection bundle, and exits into a short optical 
train, beginning with a 20x microscope lens followed by a 15cm focal length doublet 
lens, which forms an infinitely corrected microscope configuration. Before reaching the 
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doublet lens, the magnified signal travels through a mechanical lens filter with three 
bandpass wavelengths: 390±40nm, 450±40nm, and 550±88nm. These wavelengths have 
been determined to be optimal for differentiating fluorophores intrinsic to atherosclerotic 
plaques (17). The gated intensified charge-couple device (ICCD) camera (4Picos, 
Stanford Computer Optics, Berkeley, CA) records the remaining passed signal at various 
delays in 200 ps intervals, such that wide field images at different delays compile to 
form both a spatially and temporally resolved image. The spatial resolution of the 
resulting images is ~50µm, and the temporal resolution is approximately 0.5ns. The 
penetration depth of the system has been calculated to be roughly 200µm, which is 
sufficient to identify thin cap FA’s. 
 The ICCD camera recorded 51 images, each separated by 200ps in time (for a 
total recording time of 10ns). The open gate time per image was 200ps. Each image was 
comprised of 25 frames to ensure a brighter and more stable intensity map for analysis. 
Each recording took approximately 60 seconds due to slow repetition rate of the laser, 
the long integration time and high amount of frames in each recording experiment.  
   
3.2 Histology 
The coronary samples were imaged within 48 hours of receiving the tissue, 
keeping the vessels wet with Phosphorous buffer solution (10% diluted in DI water). 
After imaging, the pieces were processed following standard histopathology protocols 
and stained with Movat pentachrome. Movat staining is a common cardiovascular stain 
useful in differentiating collagen, elastin, smooth muscle cells, macrophages and 
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necrotic cores (29). Collagen is stained blue, while the external and internal elastic 
laminas show up as red with the surrounding area showing up as dense black lines (due 
to elastin). Foam cells are hollow (due being dissolved by alcohols in the preservation 
and staining process) with centrally red-stained nuclei. Lipid cores are mostly hollow 
with centrally red-stained nuclei. ms study aimed to evaluate the ability of FLIM to 
differentiate between thick cap fibroatheroma (cap >65µm) and thin cap fibroatheroma 
(cap <65µm). The groups used in this study include thin fibrotic plaque (<100µm), thick 
fibrotic plaque (>100µm), fibrocalcified plaque, thin-cap fibroatheroma, and thick-cap 
fibroatheroma. 
   
3.3 Laguerre Deconvolution and the Acquisition of the True Response 
3.3.1 Lifetime Deconvolution Techniques 
The camera records fluorescent signals that are convolutions of the impulse 
response of the fluorophore and the laser profile. Thus, to determine the proper lifetime 
of any region of the FLIM image, the fluorescence decay at each pixel of the image must 
be deconvolved. The most common methods to accomplish this include non-linear least-
square iterative reconvolution (32-33) and rapid lifetime determination (RLD) (34). The 
non-linear least-square iterative method can be a powerful technique because it does not 
assume an input profile of negligible width. This method uses a least-squares 
optimization algorithm to fit the data to a multiexponential decay model to deconvolve 
the impulse response from the input. However, this method suffers from long calculation 
times, making it a poor choice for the purpose of wide-field FLIM analysis. In contrast, 
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Rapid Lifetime Determination can deconvolve large amounts of data quickly. RLD relies 
on the fact that the input profile is of negligible size, an unfair assumption of the FLIM 
apparatus used in this study. Laguerre deconvolution, the method used in this study, 
offers both accuracy and speed in deconvolving spatially resolved FLIM data. This 
method has recently been introduced and validated as a method for deconvolving FLIM 
images (35-36). Laguerre deconvolution owes its speed to the fact that the impulse 
response at each pixel is a summation of weighted Laguerre functions, effectively 
forming a basis for the entire image. This can be performed across the entire image 
simultaneously, up to two orders of magnitude faster than previously discussed 
algorithms (35).  
 
3.3.2 Laguerre Deconvolution 
 The following equations outline the mathematics behind Laguerre deconvolution. 
The recorded intensity profile reflects the instrument response, or input, convolved with 
the fluorescence emission: 
                             
   
                 (4) 
The equation above illustrates the decay function H(rx, ry, n) in discrete time, a 
convolution of  the impulse response function (IRF) h(rx, ry, n) and the instrument 
response x(n). In this study, we will apply the Laguerre deconvolution method to recover 
the IRF at each pixel of the image, chosen for both its efficiency and accuracy in 
deconvolving images in 2D (35). In this method, the IRF is modeled as a linear 
expansion on a set of orthonormal Laguerre functions:  
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           (5) 
Here, cj(rx, ry ) denotes the Laguerre expansion coefficient (LEC) computed at 
each pixel, and the Lageurre basis function b(n) is defined as follows: 
  
                  
 
         
 
 
   
 
 
              
  (6) 
 α denotes the efficiency of b(n) to match the fluorescence decay by changing the 
rate at which the Discrete Laguerre Function decays. For any value of α, j orders can be 
used to estimate the decay function. Conversely, a set amount of orders can be used to 
optimize α for each data set. With equations 4-6, we can write an equation that describes 
the recorded image pixel by pixel using Laguerre expansions: 
                                  
            (7) 
Where: 
  
                       
   
    (8) 
Equation 6 can be written in matrix form in the following equation: 
                     (9) 
Where: 
 
      
      
 
        
   
  
      
    
  
      
    
              
    
              
    
  
  
        
      
  
     
      
  
     
     
 
       
  (10) 
An error term ε at pixel (rx, ry) was added to equation 9 to account for errors in 
measurement: 
                           (11) 
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Previous work has found that L=4 orders of the Laguerre equations sufficiently 
reproduces the deconvolved decay curve (37). The final output of the deconvolution is 
then the Laguerre expansion coefficients crx,ry,n and α, which provides the information 
needed to construct the true decay of the signal.  
   
3.4 Processing and Data Analysis 
3.4.1 Initial Processing 
 Immediately following recording of the FLIM dataset, the data was spatially 
decimated by using a moving average across the entire image set. Temporal resolution 
was preserved in order to maximize accuracy of deconvolution and lifetime 
measurements, while still decreasing the file size to something more manageable. This 
also has the added benefit of smoothing out noise in the signal due to fluctuations in the 
recorded intensities (improving the signal to noise ratio).  
The following discusses how the algorithm determines the optimal value for α in 
a given sample. In order to obtain a proper impulse response function (IRF), the correct 
value for α (0<α<1) must be determined. After decimating the image, an instrument 
response delay was selected, followed by optimizing the α parameter of the sample. In 
the following equation,   is the least-square solution for the measured decay function, 
and is an estimation of the decay function using the Laguerre vectors defined in 
equations 9 and 10: 
                
    
  
  
            (12) 
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The error of fit between the least-square estimation and the recorded signal εr can 
be defined as: 
                     (13) 
Therefore, a cost function           at a given pixel (rx,ry), or a scalar value that 
defines the quality of fit between the measured signal and fitted signal is defined as: 
                         
 
                      
         (14) 
The cost of an entire image is given as the summation of the entire image. The 
optimum value for α yields the lowest image cost function. The optimization algorithm 
uses the cost function of equation 14 by first selecting a value for α, starting with α=0.5. 
The cost function’s derivative is then calculated: the optimal value of α will yield a slope 
of 0.  
Once the algorithm finds an optimal α solution, it stores its cost, and compares it 
to the cost of other optimal α values calculated with different instrument response 
delays. Finally, the algorithm selects an optimal delay and α associated with the lowest 
cost function, and performs Laguerre deconvolution. A more detailed explanation to 
optimizing α in the case of time-resolved fluorescence spectroscopy has been published 
in (37). 
 
3.4.2 Determining Optimal α for all Datasets 
 In order to decrease processing time and allow easier correlation between 
samples, we determined a single α value that could be used for analyzing the FLIM data 
from all samples. A previous set of 83 coronary arteries had their optimal value of α and 
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histological classification determined (38). Every sample initially optimized their α 
values separately. Each sample was imaged at 390nm, 450nm, and 550nm; therefore, 
each sample had three α values. To determine if a single value for α was appropriate, α 
values were grouped into categories by their wavelength. Student’s two-tailed t-tests 
were performed between groups to determine if they were statistically similar. A p-value 
of p>0.05 was used to determine statistical significance for all t-tests performed. If 
statistically similar in all cases (390 nm vs. 450 nm, 390 nm vs. 550 nm, 450 nm vs. 550 
nm), an average of all α values at all wavelengths would be averaged to produce a single 
α value to be used in future deconvolutions.  
 
3.4.3 Measurement of the Instrument Response 
 The instrument response was measured by measuring the laser reflection on a 
mirror, which propagated into the collection bundle to be recorded by the ICCD camera. 
The recorded Full-Width Half-Maximum of the instrument response was determined to 
be ~ 1 ns, and is displayed in the Appendix (Figure A-1).  
 
3.4.4 Photobleaching Testing 
 A series of images at peak fluorescence intensity was taken over several minutes 
to explore the effects of photobleaching on the sample. The sample was illuminated for 
10 minutes, and an image was taken every minute (200 ns open gate time), starting at 
t=0 minutes for a total of 11 images. A sample of the data has been included in the 
Appendix (Figure A-2). The tissue suffered a 5% loss in fluorescence intensity at 10 
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minutes. Samples that will be used for statistical analysis take approximately 1 minute to 
record, making photobleaching negligible in our case. 
 
3.5 Parameter Correlation to Histological Features 
To produce the intensity map used in analysis, the intensities at each pixel were 
summed together into a single image. This became the overall intensity used in the 
analysis. Each sample was normalized by their respective maximum values after the sum 
of the time-resolved images was taken. The lifetime maps are lifetime values extracted 
from the impulse response functions at each pixel. The method of determining the 
impulse response function is outlined in section 3.3.2. Once the intensity maps of all 
samples were processed and deconvolved, the center region of the FLIM image, roughly 
one square millimeter, was selected for analysis. The average of the intensity, lifetime, 
and laguerre coefficients corresponding to the ROI were saved for statistical analysis. 
Each region was also assigned a histological classification based on the histological 
section correlating to the region: thin plaque, thick plaque, thin cap fibroatheroma, thick 
cap fibroatheroma, and fibrocalcified. 
 To determine if statistical significance existed between FLIM parameters and 
histological diagnosis, this study used multivariate one-paired ANOVA and student’s 
two-tailed t-testing. The multivariate ANOVA test took into account all histological 
classifications and determined statistical significance if a group’s average and spread 
differed from others. The student’s t-test determines significant differences between two 
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selected classifications. P-values of 0.05 or less were viewed as statistically significant 
for both ANOVA and student’s t-test.  
The FLIM samples were also categorized into several groups by plaque thickness 
to investigate the potential of FLIM to measure plaque depth. In order to reduce 
histological variation, plaques classified as fibrocalcified, thin-cap and thick-cap were 
not included in this analysis. Each sample’s central plaque thickness was recorded by 
measuring the sectioned sample with a microscope. These thickness measurements were 
made in the center to correspond to the center of the ROI selected on the FLIM image 
during analysis (the central 1x1 mm region). Samples were then broken into the 
following groups: plaque <0.05 mm, 0.05 mm < plaque < 0.10 mm, 0.10 mm < plaque < 
0.20 mm, and plaque > 0.20 mm. Because elastin and collagen fluorescent signals are 
unique at 390 nm, 550 nm was not considered (17).  
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4. RESULTS 
 
4.1. Results of α Value Optimization 
 As discussed in section 3.4.2, a single value for the α parameter would be 
advantageous in decreasing computation time while preserving accuracy of the Laguerre 
deconvolution. If the values of α are statistically similar regardless of emission band or 
histology grouping, a single, average value of α can be used for all samples. Table 1 
summarizes the results: 
 
Table 1. Mean and standard deviation of α values, and p-value comparison of groups by 
wavelength. 
Wavelength Mean ± SE Comparison p-value 
390 nm 0.8096 ± 0.0004 390nm vs. 450nm 0.8872 
450 nm 0.8102 ± 0.0003  390nm vs. 550nm 0.1756 
550 nm 0.8157 ± 0.0003 450nm vs. 550nm 0.1250 
 
 
 
 Because all groupings were similar and had a p value of p > 0.05, an average 
value of α=0.8118 was determined to be a sufficient approximation for all samples. 
 
4.2 Histological Data  
 The data was classified into 9 groupings: 20 thin plaques, 60 fibrotic plaques, 1 
thin cap FA, 12 thick cap FA, 17 fibrocalcified (a total of 110). Two samples 
representing coronary plaque can be seen in figure 2 and figure 3, as well as their 
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corresponding FLIM images. In the histological stains, both thin and fibrotic samples are 
given, respectively, which is reflected by the FLIM images by their differences in 
relative intensity and lifetime. The movat pentachrome stain causes the collagen to be 
light blue, whereas the internal and external elastic laminas contain dense, dark lines due 
to the elastin. Lipids are clear and were dissolved and removed due to the alcohols used 
in tissue preparation prior to sectioning and staining- few lipids are seen in the figures 
below. Foam cells, or lipid-filled inflammatory and smooth muscle cells, manifest 
themselves as clear spaces with red stained dots, representing the nucleus of the cell.  
The FLIM images in figure 2 show that elastin is the dominant fluorophore in the 
vessel. Although there is some collagen present in the thin layer of plaque, and this 
signal did affect the overall recorded emission, the underlying elastin of the external 
elastic lamina contributed to the majority of the signal, as seen by a spike in intensity at 
450nm, and smaller lifetimes across the recorded emission wavelengths. Figure 3, on the 
other hand, is dominated by the collagen found in the fibrotic plaque. The relative 
intensities of the corresponding FLIM images decrease with increasing wavelength, and 
the fluorescence lifetimes are higher than in thin plaque, which is expected (38). 
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Figure 2. Thin plaque histology and corresponding FLIM image recorded at 390nm, 450nm, and 550nm wavelengths. The 
elastin from the lamina dominates the fluorescent signal. This is indicated by a higher intensity at 450nm, and lower lifetime 
values. 
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Figure 3. Fibrotic plaque histology and corresponding FLIM image recorded at 390nm, 450nm, and 550nm wavelengths. The 
collagen from the plaque dominates the fluorescent signal. This is indicated by higher relative intensities at lower wavelengths, 
which gradually decrease, and higher lifetime values. 
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4.3 FLIM Data Analysis 
4.3.1 Histological Grouping Analysis 
There was one thin-cap fibroatheroma in all samples recorded. There were 12 
thick-cap FA’s present. The following results focus on differentiating thin plaques, 
fibrotic plaques, and fibrocalcified plaques. When thick cap FA and fibrotic plaque 
samples were separated, their means and standard deviations overlapped significantly on 
both lifetime and intensity for all wavelengths, making them similar by the FLIM 
parameters used in this study. Therefore, fibrotic plaque samples were consolidated with 
thick-cap FA samples due to similarities in their signal. Table 2 shows the p-values 
associated with the ANOVA testing of the FLIM image’s histological groupings 
remaining after consolidating inflamed groups to their non-inflamed counterparts, 
fibrotic and thick-cap FA, and removing thin-cap FA.  
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Table 2. ANOVA and t-test p-values at 390, 450, and 550 nm for FLIM Intensity, Lifetime, and first two Laguerre 
coefficients. The histological groupings were consolidated into the following groups: a) Thin, b) Fibrotic and Thick Cap FA, 
and c) Fibrocalcified. 
FLIM 
Parameter 
Band 
(nm) 
Thin Fibrotic Fibro-
Calcified 
ANOVA 
p-value 
Thin v. 
Fibrotic 
p-value 
Thin v. 
Fibro-
Calcified 
p-value 
Fibrotic v. 
Fibro-
Calcified 
p-value 
Normalized 
Intensity 
390 0.3410 + 
0.0196 
0.3972 + 
0.0103 
0.3935 + 
0.0213 
0.0410 0.0007 
 
0.0719 
 
0.8950 
 
450 0.4604 + 
0.0123 
0.4143 + 
0.0065 
0.4057 + 
0.0133 
0.0024 0.0002 
 
0.0093 
 
0.6432 
 
550 0.1987 + 
0.0099 
0.1885 + 
0.0052 
0.2008 + 
0.0108 
0.4640 - - - 
Lifetime (ns) 390 1.1542 + 
0.0827 
1.5620 + 
0.0436 
1.4537 + 
0.0897 
0.0002 3.75E-06 
 
0.0085 
 
0.2814 
 
450 1.4057 + 
0.0812 
1.4872 + 
0.0428 
1.5854 + 
0.0880 
0.3282 - - - 
550 1.3718 + 
0.0785 
1.6210 + 
0.0414 
1.5692 + 
0.0851 
0.0223 0.0005 
 
0.0748 
 
0.6186 
 
LEC 1 390 0.7552 + 
0.0164 
0.8305 + 
0.0087 
0.8232 + 
0.0178 
0.0004 0.001206 
 
0.0187 
 
0.4735 
 
450 0.8134 + 
0.0135 
0.8240 + 
0.0071 
0.8304 + 
0.0147 
0.6778 - - - 
550 0.8234 + 
0.0126 
0.8236 + 
0.0066 
0.8257 + 
0.0137 
0.9892 - - - 
LEC 2 390 0.1052 + 
0.0171 
0.0166 + 
0.0090 
0.0422 + 
0.0186 
0.0001 5.96E-06 
 
0.0156 
 
0.3230 
 
450 0.0491 + 
0.0144 
0.0119 + 
0.0076 
0.0102 + 
0.0157 
0.0675 - - - 
550 0.0186 + 
0.0136 
-0.0198 + 
0.0071 
-0.0057 + 
0.0147 
0.0442 0.4995 
 
0.3317 
 
0.3216 
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The histological grouping is most evident at 390nm, where the intensity, lifetime, 
LEC 1 and LEC 2 show statistical differences with at least one grouping via ANOVA p-
values (in bold). At the 450nm band, only the intensity parameter yielded significantly 
significant results. At 550nm, both the lifetime parameter and LEC 2 was statistically 
significant. This trend of lower wavelengths yielding more statistically meaningful 
results matches previous findings: thin plaques generally show the most dramatic 
changes in intensity between thin and thick plaques at 390 nm. In addition, lifetimes for 
elastin-rich regions were shorter than collagen-rich regions at 390nm (38). It is important 
to note that these trends are observed with plaque samples containing very little lipids. 
The p-values reported on Table 2 also show that the fibrocalcified plaque is 
indistinguishable from fibrotic plaque. Fibrocalcified plaques were generally thick layers 
of plaque over 100µm. Because calcium does not possess a strong fluorescent signal, 
collagen dominated the fluorescence emission of these samples. Figure 4 shows a 
multicomparison of the statistically significant parameters outlined in bold in Table 2.  
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Figure 4. Multicomparison test results of significant (p<0.05) parameters when 
analyzing by histological grouping. 100µm threshold between thin and fibrotic plaques. 
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Figure 4. Continued. 
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Figure 4. Continued 
 
4.3.2 Fibrotic Plaque Thickness Analysis  
 An analysis of fibrotic plaque thickness was also performed. Thin and fibrotic 
and plaques were grouped into categories by thickness range, and their average intensity 
and lifetime were compared at 390 nm and 450 nm wavelengths. The results are 
displayed on Figure 5.  
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Figure 5. Intensity (top) and lifetime (bottom) Comparison of data grouped by plaque 
thickness at 390 nm. Error bars denote standard error. 
 
 The intensity (top) data on figure 5 shows that the values remain fairly constant 
as thickness increases, but there is a sudden shift in intensity for both wavelengths when 
the plaques grow beyond 0.20 mm thickness. Beyond this, the intensity at both 
wavelengths converge and broaden in their intensity reading (hence the large standard 
deviation).  
 The lifetime (bottom) values show a more gradual shift as thickness increases. At 
0.10 mm, the wavelength measurements merge.  The overall positive trend between 
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plaque thickness and lifetime at 390nm is expected, and corresponds with previous work 
(38).  
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5. DISCUSSION AND CONCLUSIONS 
 
 
 
5.1 Discussion 
 
 This study tests the validity of our Fluorescence Lifetime Imaging Microscopy 
(FLIM) system to differentiate atherosclerotic plaque types into several histological 
groupings: Thin, fibrotic, thin cap FA, thick cap FA, and fibrocalcified plaques. After 
recording temporally resolved images of the artery samples at three critical wavelengths 
(390nm, 450nm, and 550nm) (38), we performed Laguerre deconvolution on the 
samples to obtain the true fluorescent response, which has been reported to be 
advantageous over least-square iterative reconvolution (39). Using histological sample 
classifications to categorize the FLIM images into these groups, statistical analyses were 
performed in order to determine if the relative intensity, lifetime measurement, and 
Laguerre expansion coefficients may be used to differentiate histological groupings. The 
findings of this study are in agreement with previous results in that thin plaque is 
differentiable from fibrotic plaque and thick cap FA plaques. There were not enough thin 
cap FA plaques in the dataset, however, to draw any statistically significant conclusions 
regarding the system’s ability to successfully detect shallow lipid cores. The following 
section discusses the results of the study, their implications, and problems that should be 
addressed.  
In order to decrease computation requirements, the α parameter used in Laguerre 
deconvolution was investigated in an attempt to set it to a single value. The α 
optimization, discussed in section 3.4.2, determined an optimal value for calculating the 
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Lageurre expansion coefficients in all samples. The α value was determined to be 
α=0.8118. Doing so proved to be much less computationally expensive than optimizing 
on a sample-by-sample model and allowed the expansion coefficients and lifetimes to be 
determined and compared to all samples in the experimental data set. There were 
limitations in doing this, however. By setting a static value that is not optimized by a 
case by case basis, the Laguerre fits are not perfect, and may adversely affect lifetime 
calculations. However, all fits had less than 5% error between the estimated response 
curves constructed by LEC coefficients and recorded response curve. 
The results from ANOVA testing of cap thickness (section 4.4.1) did not yield a 
difference between fibrotic plaque and thick-cap FA. This is expected, because a large 
collagen region thicker than the penetration depth of the excitation beam will return 
primarily a collagen signature. A 100µm threshold was used to differentiate thin plaques 
and thick fibrotic plaque classifications. This threshold was able to differentiate thin 
plaque, whose fluorescent signal is dominated by elastin, from thick plaque, whose 
fluorescent signal is dominated by collagen. Fibrocalcified plaques displayed an 
emission very similar to fibrotic plaques. Calcification is a sign of a late-stage plaque, 
and can be detected by some other intravascular modalities, namely IVUS and Electron 
beam computed tomography (EBCT) (40). The fibrocalcified samples were generally 
thick. Because collagen is the primary fluorophore in normal plaque without lipids, it 
made up the majority of the signal for plaques labeled as fibrocalcified. For many of the 
statistically significant parameters (Lifetime, LEC-1, LEC-2 at 390nm, and Intensity at 
450nm), fibrocalcified plaque was discernable from thin plaques. Additionally, there 
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were no thin-cap FA samples. A larger dataset may have yielded vulnerable plaques in 
order to analyze. Analysis by cholesterol composition was similar to analysis by plaque 
thickness and calcification. Cholesterol-laden plaque, which was plaque containing 
cholesterol and foam cells within the first 200µm of the lesion, followed the same trend 
as fibrotic plaque and was statistically different only from thin plaque, indicating that 
collagen dominated the FLIM signal. 
When investigating FLIM signals as a function of plaque thickness, both 
intensity and lifetime measurements at 390 nm correlated to sample’s dominant 
fluorophores. The change in intensity was very sudden as plaque thickness grew above 
0.20 mm, however. In contrast, lifetime measurements of plaque showed a more gradual 
trend of increasing lifetime with plaque thickness, beginning at ~1.1 ns for plaques less 
than 0.05 mm thick, rising to 1.55 ns with plaques greater than 0.20 mm thick. This 
gradual shift suggests that lifetime may indirectly reflect plaque thickness. To determine 
if this is a meaningful trend, this test should be performed on a larger dataset. This 
analysis should also be performed with thin-plaque samples at 390 nm and 550 nm: 390 
nm to discern cap thickness, and 550 nm to determine lipid content of the underlying 
core.  
Both analyses provided consistent trends that matched previous studies (38). 
However, some inconsistencies exist with previous research, namely lifetime 
measurements of fibrotic plaque, whose primary fluorophore is collagen. This study 
found that collagen-dominated plaques had an average lifetime of 1.56ns, 1.49ns, and 
1.62ns for 390nm, 450nm, and 550nm wavelengths, respectively (See: Table 2). Thick 
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plaque lifetime values in previous studies yielded higher lifetime values at 2 ns for 390 
nm, however (38). Elastin-dominated plaque lifetimes were within acceptable range, and 
also generally lower than collagenous plaques with lifetimes of 1.15ns, 1.41ns, and 
1.37ns for 390nm, 450nm, and 550nm, respectively. This indicates a possible 
discrepancy in calculating the lifetime. Although the fits between the estimated Laguerre 
response and the measured response had very small errors (<5% in all cases), lifetime 
values were not as high as expected. A closer look into the α parameter optimization 
may be necessary to explore the reasoning behind this, however. The set α value used in 
this study was determined by a previous dataset, and may not have fully represented the 
dataset collected for statistical analysis.   
The single-lifetime modeling scheme used in this study calculates a single 
lifetime value, and has the advantage of being computationally less expensive than 
multi-lifetime models, such as multiexponential approximations, due to its 
deconvolution technique (35). However, the downside to this is that a multi-fluorophore 
sample, such as arterial plaques, will not have all fluorophores directly represented by 
the model. This problem is rectified by the model used to represent the decay curve: 
Lageurre deconvolution is a summation of decaying lageurre curves, and is a function of 
both lageurre expansion coefficients and the α parameter, both optimized to estimate the 
time-resolved fluorescence emissions. Because this model uses multiple expansion 
coeffiencents to estimate the emission curve, it is safe to say that the Lageurre 
coefficients may be able to differentiate multiple fluorophores inside a sample. It is 
important to recognize that these expansion coefficients function similarly to a 
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summation of decay curves with multiple time-constants in that they make up the total 
decay. However, it would be advantageous to perform a comparison between the 
lageurre coeffiecients and multiexponential lifetime coefficients for different plaque 
types. Doing so will allow for a more sound comparison between studies that utilize the 
multiexponential lifetime model. Using a multiexponential model also takes into account 
the multiple fluorophores found in the field of view. 
 
5.2 Future Scope 
 Testing on the current FLIM system should be expanded to fully analyze the 
ability of this FLIM angioscopy prototype to detect vulnerable plaques. As discussed 
above, several problems exist that should be addressed, such as unusually low lifetimes 
of collagen and the lack of vulnerable plaque samples. A future study should further 
investigate lifetime as a function of plaque thickness and determine why the lifetime 
values in this study are lower than normal in the case of fibrotic plaques. If the trend 
between lifetime and plaque thickness holds true for future tests, thin-cap FA samples 
should be measured at both 390 nm and 550 nm wavelengths. By using 550 nm to 
confirm or deny lipid core presence, lifetime at 390 nm may reflect cap thickness rather 
than plaque thickness. Future studies should also focus on the edge of plaque lesions in 
order to increase the chance to image vulnerable regions. Additionally, future studies 
should seek to image vessel samples that are not laid flat, with their shape intact. This 
should provide a more realistic view of the vessels imaged. Finally, a study of compiled 
thin-cap FA plaques must be performed against both thin plaques and fibrotic plaques.  
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 Another course would be to utilize the strengths of FLIM as a biochemical 
detection scheme to supplement other optical angioscopy techniques, namely OCT. Its 
potential has been established recently (29), and may produce positive results in 
identifying vulnerable plaque, among other histological conditions.  
 
5.3 Conclusions 
A FLIM angioscopy system and post-processing techniques have been tested for 
their ability to analyze coronary artery samples for their biochemical content. The 
Laguerre deconvolution method used to process the data has proved to be efficient at 
extracting the impulse response in excised coronary vessel lumen. Several experiments 
have been proposed to further validation testing of the current FLIM system, including 
correlating plaque thickness to lifetime measurements and an extended, focused study on 
thin-cap FA specimens. The trends presented here show potential for the current FLIM 
and statistical analysis system to identify plaques; provided several processing 
techniques are made to correct for errors that have been identified and discussed in this 
research summary. 
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APPENDIX 
 
 
 
 
Figure A-1. Recorded instrument response x(n) used to deconvolve samples. 
 
 
 
 
Figure A-2. Photobleaching effect on coronary tissue sample over 10 minutes.  
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